AI & Finance News ・ 🛡️ Insurance

AI due diligence in buy-side PE transactions: The new AI risks buyers are underwriting

Norton Rose Fulbright 🔗 Share link 11/10 08:22 UTC 🔗 Share link Charta Health raises $55M to scale AI chart review for insurers — Dealroom · 11/10 14:45 UTC

Private equity buyers are no longer treating artificial intelligence as a niche diligence issue. It was previously reserved for targets whose product and service offerings primarily focus on AI.

Read the original (Norton Rose Fulbright 🔗 Share link 11/10 08:22 UTC 🔗 Share link Charta Health raises $55M to scale AI chart review for insurers — Dealroom)

See it in the digest → ・ See this issue →